EpiPen competitor will release the Auvi-Q on Feb.14 at a price of $4,500. This includes two talking epinephrine auto-injectors and a program called Auvi-Q Affordability.
The U.S. Food and Drug Administration (FDA) approves the first drug intended to treat Marginal Zone Lymphoma (MZL).
Fast, cheap and efficient. This best describes the newly developed mobile microscope that can analyze DNA immediately.
A drug usually used to combat malaria has been used in patients with brain cancer and do not respond to the targeted treatments.
Cholesterol-lowering drugs could prevent the formation of blood clots in the vein by as much as 25 percent.
Everett sued Purdue Pharmaceuticals company for allowing the OxyContin sales on the streets. This has caused opioid and heroin addiction in several cities.
Breast cancer cells are very difficult to treat and investigators found out what protected these tumor cells.
The controversial Theranos blood-testing company closed its last laboratory after failing another U.S. inspection.
Turmeric, the spice considered as a superfood, may not be as therapeutic as everyone thought it was, a new research suggests.
Physical activity may help mitigate the side effects of hormone-therapy drugs among breast cancer survivors.
The high prices for orphan drugs strained its consumers as low-income families finds it nearly impossible to purchase a $300,000-a-year drug.
Technology advancements have found their way towards tedious occupations and the latest one in focus is one tied up with health and medicine. This has something to do with a robotic system tasked to aid doctors by doing the actual work that is normally left at the surgeon’s hands.
Traditional Chinese medicinal plant, Huang-Qin, has “pathways” to produce chemicals that could fight cancer and liver disease.
National Prescription Drug Take-Back Day is this Saturday, October 26, 2013. Sites all around the United States are offering services in which you can safely dispose of expired or unused prescription medications.
Japanese drug manufacturer Takeda Pharmaceutical Co. and U.S.-based Affymax Inc. issued a recall on Sunday of their anemia drug Omontys used for kidney dialysis patients following reports of serious hypersensitivity reactions among several users which even resulted in some deaths.